Annexon, Inc. (ANNX) stock
ANNXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.52+0.05 (+1.44%)
Close on Nov 18, 2026Market cap $719.65MP/E –Yield 0.00%
Annexon net income
Net income is the profit left for shareholders after every expense, interest and tax.
Annexon's net income for the twelve months ending Jun 30, 2026 was -$202.67M. For fiscal 2025 it was -$206.69M. The highest annual figure on record is -$37.18M in fiscal 2019.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$206.69M | – |
| FY2024 | Dec 31, 2024 | -$138.20M | – |
| FY2023 | Dec 31, 2023 | -$134.24M | – |
| FY2022 | Dec 31, 2022 | -$141.95M | – |
| FY2021 | Dec 31, 2021 | -$130.32M | – |
| FY2020 | Dec 31, 2020 | -$63.41M | – |
| FY2019 | Dec 31, 2019 | -$37.18M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$55.35M | – |
| Q1 FY2026 | Mar 31, 2026 | -$44.14M | – |
| Q4 FY2025 | Dec 31, 2025 | -$48.26M | – |
| Q3 FY2025 | Sep 30, 2025 | -$54.92M | – |
| Q2 FY2025 | Jun 30, 2025 | -$49.16M | – |
| Q1 FY2025 | Mar 31, 2025 | -$54.36M | – |
| Q4 FY2024 | Dec 31, 2024 | -$48.59M | – |
| Q3 FY2024 | Sep 30, 2024 | -$34.82M | – |
| Q2 FY2024 | Jun 30, 2024 | -$29.61M | – |
| Q1 FY2024 | Mar 31, 2024 | -$25.18M | – |
| Q4 FY2023 | Dec 31, 2023 | -$27.89M | – |
| Q3 FY2023 | Sep 30, 2023 | -$32.48M | – |
| Q2 FY2023 | Jun 30, 2023 | -$35.19M | – |
| Q1 FY2023 | Mar 31, 2023 | -$38.68M | – |
| Q4 FY2022 | Dec 31, 2022 | -$34.38M | – |
| Q3 FY2022 | Sep 30, 2022 | -$35.05M | – |
| Q2 FY2022 | Jun 30, 2022 | -$37.14M | – |
| Q1 FY2022 | Mar 31, 2022 | -$35.37M | – |
| Q4 FY2021 | Dec 31, 2021 | -$37.37M | – |
| Q3 FY2021 | Sep 30, 2021 | -$35.60M | – |
| Q2 FY2021 | Jun 30, 2021 | -$31.29M | – |
| Q1 FY2021 | Mar 31, 2021 | -$26.06M | – |
| Q4 FY2020 | Dec 31, 2020 | -$23.19M | – |
| Q3 FY2020 | Sep 30, 2020 | -$15.64M | – |
| Q2 FY2020 | Jun 30, 2020 | -$12.24M | – |
| Q1 FY2020 | Mar 31, 2020 | -$12.34M | – |
| Q4 FY2019 | Dec 31, 2019 | -$8.94M | – |
| Q3 FY2019 | Sep 30, 2019 | -$10.19M | – |
| Q2 FY2019 | Jun 30, 2019 | -$9.40M | – |
| Q1 FY2019 | Mar 31, 2019 | -$8.65M | – |
See a number that looks wrong?